Please login to the form below

Not currently logged in
Email:
Password:

anticoagulants

This page shows the latest anticoagulants news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s flat sales focus investor attention on M&A

Pfizer’s flat sales focus investor attention on M&A

Once again, cancer drug Ibrance (palbociclib), anticoagulant Eliquis (apixaban) and Xeljanz (tofacitinib) for arthritis and other immunological indications led the charge, backed up by a solid advance for paediatric vaccine Prevnar

Latest news

More from news
Approximately 17 fully matching, plus 205 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    Canada. Nonetheless, new rival innovation in the anticoagulant market is already presenting challenges for Xarelto. ... This was largely thanks to Eliquis overtaking Bayer’s Xarelto as the leader in novel oral anticoagulants.

  • Digital disruption in market access Digital disruption in market access

    publication of the first direct oral anticoagulant technology appraisal, we are not yet there.

  • The pill branding The pill branding

    For example, if names suggest that the medication belongs to gastroenterology, although it is an anticoagulant, the name may be the source for medical errors.

  • Pharma deals in May 2015 Pharma deals in May 2015

    245. Isis/ Bayer. Licence agreement. Anticoagulant ISIS FXIRx for prevention of thrombosis in P2.

  • Deal Watch table for January 2015 Deal Watch table for January 2015

    Licence, option and collaboration. 164. Novartis/Aspen. Purchase of the heparin based anticoagulant Mono-Embolex, with sales of 68m in 2013.

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics